3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
25
Peritoneal Neoplasms
17
Fallopian Tube Neoplasms
11
Carcinoma, Ovarian Epithelial
6
Stomach Neoplasms
5
Colorectal Neoplasms
4
Colonic Neoplasms
3
Adrenocortical Carcinoma
3
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Neoplasms
2
Mesothelioma
2
Hyperthermia
2
Gastrointestinal Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Postoperative Complications
1
Pelvic Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Low Anterior Resection Syndrome
1
Liposarcoma
1
High Grade Serous Ovarian
1
Brenner Tumor
1
Interventions
pembrolizumab
23
Paclitaxel
14
Cyclophosphamide
13
Carboplatin
12
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
Biopsy
9
fludarabine
8
Nivolumab
7
Leucovorin
7
Gemcitabine
7
Fluorouracil
7
Doxorubicin
7
aldesleukin
6
Oxaliplatin
6
Cisplatin
6
liposomal doxorubicin
5
Topotecan
5
Taxes
5
Irinotecan
5
Interleukin-2
5
olaparib
4
atezolizumab
4
Hyperthermic Intraperitoneal Chemotherapy
4
Drug Therapy
4
seribantumab
3
fludarabine phosphate
3
durvalumab
3
dostarlimab
3
dehydroftorafur
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Cytoreduction Surgical Procedures
×
Gynecologic
×
Clear all
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled